Retroviral insertional mutagenesis: Tagging cancer pathways

Advances in Cancer Research

Volumn 88, Issue , 2003, Pages 53-99

  Mikkers, Harald ^a   Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTRANSFORMATION; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL DIVISION; CELL TRANSFORMATION; DATA BASE; DNA MODIFICATION; HUMAN; MOLONEY LEUKEMIA ONCOVIRUS; MUTAGENESIS; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; PROTEOMICS; PROTO ONCOGENE; RETROVIRUS; REVIEW; SCREENING; SIGNAL TRANSDUCTION; SUPERINFECTION; TISSUE SPECIFICITY; VIRUS ISOLATION; VIRUS REPLICATION; WILD TYPE;

EID: 0037235453     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(03)88255-6     Document Type: Review

References (245)

1. Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., and Brinster, R. L. (1985). The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533-538.
2. Adnane, J., Gaudray, P., Simon, M. P., Simony-Lafontaine, J., Jeanteur, P., and Theillet, C. (1989). Proto-oncogene amplification and human breast tumor phenotype. Oncogene 4, 1389-1395.
3. Afanasieva, T. A., Pekarik, V., Grazia D'Angelo, M., Klein, M. A., Voigtlander, T., Stocking, C., and Aguzzi, A. (2001). Insertional mutagenesis of preneoplastic astrocytes by Moloney murine leukemia virus. J. Neurovirol. 7, 169-181.
4. Afonja, O., Smith, J. E., Jr., Cheng, D. M., Goldenberg, A. S., Amorosi, E., Shimamoto, T., Nakamura, S., Ohyashiki, K., Ohyashiki, J., Toyama, K., and Takeshita, K. (2000). MEIS1 and HOXA7 genes in human acute myeloid leukemia. Leuk. Res. 24, 849-855.
5. Albritton, L. M., Tseng, L., Scadden, D., and Cunningham, J. M. (1989). A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57, 659-666.
6. Alexander, W. S., Schrader, J. W., and Adams, J. M. (1987). Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice. Mol. Cell Biol. 7, 1436-1444.
7. Alitalo, K., Winqvist, R., Lin, C. C., de la Chapelle, A., Schwab, M., and Bishop, J. M. (1984). Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA 81, 4534-4538.
8. Allen, J. D., Verhoeven, E., Domen, J., van der Valk, M., and Berns, A. (1997). Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15, 1133-1141.
9. Arnold, A., Kim, H. G., Gaz, R. D., Eddy, R. L., Fukushima, Y., Byers, M. G., Shows, T. B., and Kronenberg, H. M. (1989). Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest. 83, 2034-2040.
10. Askew, D. S., Li, J., and Ihle, J. N. (1994). Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame. Mol. Cell Biol. 14, 1743-1751.
11. Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. E., Nakamura, Y. et al. (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244, 217-221.
12. Barker, C. S., Bear, S. E., Keler, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Yeung, R. S., and Tsichlis, P. N. (1992). Activation of the prolactin receptor gene by promoter insertion in a Moloney murine leukemia virus-induced rat thymoma. J. Virol. 66, 6763-6768.
13. Bartholomew, C., Morishita, K., Askew, D., Buchberg, A., Jenkins, N. A., Copeland, N. G., and Ihle, J. N. (1989). Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene 4, 529-534.
14. Baumbach, W. R., Colston, E. M., and Cole, M. D. (1988). Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor. J. Virol. 62, 3151-3155.
15. Bea, S., Ribas, M., Hernandez, J. M., Bosch, E, Pinyol, M., Hernandez, L., Garcia, J. L., Flores, T., Gonzalez, M., Lopez-Guillermo, A., Piris, M. A., Cardesa, A., Montserrat, E., Miro, R., and Campo, E. (1999). Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93, 4365-4374.
16. Bea, S., Tort, E, Pinyol, M., Puig, X., Hernandez, L., Hernandez, S., Fernandez, P. L., van Lohuizen, M., Colomer, D., and Campo, E. (2001). BMI-1 gene amplification and over-expression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 61, 2409-2412.
17. Bear, S. E., Bellacosa, A., Lazo, P. A., Jenkins, N. A., Copeland, N. G., Hanson, C., Levan, G., and Tsichlis, P. N. (1989). Provirus insertion in Tpl-1, an Ets-1-related oncogenesis associated with tumor progression in Moloney murine leukemia virus-induced rat thymic lymphomas. Proc. Natl. Acad. Sci. USA 86, 7495-7499.
18. Bedigian, H. G., Taylor, B. A., and Meier, H. (1981). Expression of murine leukemia viruses in the highly lymphomatous BXH-2 recombinant inbred mouse strain. J. Virol. 39, 632-640.
19. Belli, B., Patel, A., and Fan, H. (1995). Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation. J. Virol. 69, 1037-1043.
20. Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S., and Bernstein, A. (1988). Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene 3, 179-185.
21. Bergeron, D., Houde, J., Poliquin, L., Barbeau, B., and Rassart, E. (1993a). Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias. Leukemia 7, 954-962.
22. Bergeron, D., Houde, J., Poliquin, L., Barbeau, B., and Rassart, E. (1993b). Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias. Leukemia 7, 954-962.
23. Bergeron, D., Poliquin, L., Houde, J., Barbeau, B., and Rassart, E. (1992). Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-EMuLV-induced non-T-, non-B-cell leukemias. Virology 191, 661-669.
24. Berkowitz, R. D., and Goff, S. P. (1993). Point mutations in Moloney murine leukemia virus envelope protein: Effects on infectivity, virion association, and superinfection resistance. Virology 196, 748-757.
25. Blankenstein, T., Qin, Z. H., Li, W. Q., and Diamantstein, T. (1990). DNA rearrangement and constitutive expression of the interleukin 6 gene in a mouse plasmacytoma. J. Exp. Med. 171, 965-970.
26. Bos, J. L., Toksoz, D., Marshall, C. J., Verlaan-de Vries, M., Veeneman, G. H., van der Eb, A. J., van Boom, J. H., Janssen, J. W., and Steenvoorden, A. C. (1985). Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 315, 726-730.
27. Bos, J. L., Verlaan-de Vries, M., Jansen, A. M., Veeneman, G. H., van Boom, J. H., and van der Eb, A. J. (1984). Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization. Nucleic Acids Res. 12, 9155-9163.
28. Bravo, P., Agustin, B. D., Bellas, C., Gonzalez, D., Camara, C., Fuertes, I. F., Almeida, J., Sanz, R. G., Orfao, A., and Escribano, L. (2000). Expression of high amounts of the CD117 molecule in a case of B-cell non-Hodgkin's lymphoma carrying the t(14:18) translocation. Am. J. Hematol. 63, 226-229.
29. Brookes, S., Lammie, G. A., Schuuring, E., Dickson, C., and Peters, G. (1992). Linkage map of a region of human chromosome band 11q13 amplified in breast and squamous cell tumors. Genes Chromosomes Cancer 4, 290-301.
30. Buchberg, A. M., Bedigian, H. G., Jenkins, N. A., and Copeland, N. G. (1990). Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol. Cell Biol. 10, 4658-4666.
31. Bui, T. D., Rankin, J., Smith, K., Huguet, E. L., Ruben, S., Strachan, T., Harris, A. L., and Lindsay, S. (1997). A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene 14, 1249-1253.
32. Burnett, R. C., David, J. C., Harden, A. M., Le Beau, M. M., Rowley, J. D., and Diaz, M. O. (1991). The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2. Genes Chromosomes Cancer 3, 461-467.
33. Buschges, R., Weber, R. G., Actor, B., Lichter, P., Collins, V. P., and Reifenberger, G. (1999). Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain Pathol. 9, 435-442; discussion 432-433.
34. Capon, D. J., Seeburg, P. H., McGrath, J. P., Hayflick, J. S., Edman, U., Levinson, A. D., and Goeddel, D. V. (1983). Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304, 507-513.
35. Celis, J. E., Wolf, H., and Ostergaard, M. (2000). Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis 21, 2115-2121.
36. Chang, F., and Nurse, P. (1996). How fission yeast fission in the middle. Cell 84, 191-194.
37. Chatis, P. A., Holland, C. A., Hartley, J. W., Rowe, W. P., and Hopkins, N. (1983). Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80, 4408-4411.
38. Chatis, P. A., Holland, C. A., Silver, J. E., Frederickson, T. N., Hopkins, N., and Hartley, J. W. (1984). A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52, 248-254.
39. Chen, X. P., Losman, J. A., Cowan, S., Donahue, E., Fay, S., Vuong, B. Q., Nawijn, M. C., Capece, D., Cohan, V. L., and Rothman, P. (2002). Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc. Natl. Acad. Sci. USA 99, 2175-2180.
40. Cole, A. R., Ji, H., and Simpson, R. J. (2000). Proteomic analysis of colonic crypts from normal, multiple intestinal neoplasia and p53-null mice: a comparison with colonic polyps. Electrophoresis 21, 1772-1781. [pii].
41. Collins, S., and Groudine, M. (1982). Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298, 679-681.
42. Corcoran, L. M., Adams, J. M., Dunn, A. R., and Cory, S. (1984). Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion. Cell 37, 113-122.
43. Cuypers, H. T., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., and Berns, A. (1984a), Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region, Cell 37, 141-150.
44. Cuypers, H. T., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., and Berns, A. (1984b), Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region. Cell 37, 141-150.
45. Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., and Croce, C. M. (1982). Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79, 7824-7827.
46. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G. et al. (1992). Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359, 162-165.
47. Devon, R. S., Porteous, D. J., and Brookes, A. J. (1995). Splinkerettes-improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res. 23, 1644-1645.
48. Diaz, M. O., Le Beau, M. M., Pitha, P., and Rowley, J. D. (1986). Interferon and c-ets-1 genes in the translocation (9;11)(p22;q23) in human acute monocytic leukemia. Science 231, 265-267.
49. Dievart, A., Beaulieu, N., and Jolicoeur, P. (1999). Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 18, 5973-5981.
50. Dolcetti, R., Rizzo, S., Viel, A., Maestro, R., De Re, V., Feriotto, G., and Boiocchi, M. (1989). N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas. Oncogene 4, 1009-1014.
51. Dong, F., Hoefsloot, L. H., Schelen, A. M., Broeders, C. A., Meijer, Y., Veerman, A. J., Touw, I. P., and Lowenberg, B. (1994). Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA 91, 4480-4484.
52. Dreyfus, F., Sola, B., Fichelson, S., Varlet, P., Charon, M., Tambourin, P., Wendling, F., and Gisselbrecht, S. (1990). Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. Leukemia 4, 590-594.
53. Duhrsen, U., Stahl, J., and Gough, N. M. (1990). In vivo transformation of factor-dependent hemopoietic cells: role of intracisternal A-particle transposition for growth factor gene activation. EMBO J. 9, 1087-1096.
54. Elder, J. H., Gautsch, J. W., Jensen, F. C., Lerner, R. A., Hartley, J. W., and Rowe, W. P. (1977). Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc. Natl. Acad. Sci. USA 74, 4676-4680.
55. Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., and Sklar, J. (1991). TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649-661.
56. Engers, R., Zwaka, T. P., Gohr, L., Weber, A., Gerharz, C. D., and Gabbert, H. E. (2000). Tiam1 mutations in human renal-cell carcinomas. Int. J. Cancer 88, 369-376.
57. Fischer, U., Meltzer, P., and Meese, E. (1996). Twelve amplified and expressed genes localized in a single domain in glioma. Hum. Genet. 98, 625-628.
58. Flubacher, M. M., Bear, S. E., and Tsichlis, P. N. (1994). Replacement of interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-forming (MCF) or xenotropic virus-induced IL-9-dependent autocrine loop: implications for MCF virus-induced leukemogenesis. J. Virol. 68, 7709-7716.
59. Fountain, J. W., Wallace, M. R., Brereton, A. M., O'Connell, P., White, R. L., Rich, D. C., Ledbetter, D. H., Leach, R. J., Fournier, R. E., Menon, A. G. et al. (1989). Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17. Am. J. Hum. Genet. 44, 58-67.
60. Fung, Y. K., Crittenden, L. B., and Kung, H. J. (1982). Orientation and position of avian leukosis virus DNA relative to the cellular oncogene c-myc in B-lymphoma tumors of highly susceptible 1515 X 7(2) chickens. J. Virol. 44, 742-746.
61. Gallahan, D., and Callahan, R. (1987). Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors. J. Virol. 61, 66-74.
62. Gilbert, D. J., Neumann, P. E., Taylor, B. A., Jenkins, N. A., and Copeland, N. G. (1993). Susceptibility of AKXD recombinant inbred mouse strains to lymphomas. J. Virol. 67, 2083-2090.
63. Gilks, C. B., Bear, S. E., Grimes, H. L., and Tsichlis, P. N. (1993). Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol. Cell Biol. 13, 1759-1768.
64. Girard, L., and Jolicoeur, P. (1998). A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTV(D)/myc transgenic mice. Oncogene 16, 517-522.
65. Gisselbrecht, S., Fichelson, S., Sola, B., Bordereaux, D., Hampe, A., Andre, C., Galibert, F., and Tambourin, P. (1987). Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature 329, 259-261.
66. Golemis, E., Li, Y., Fredrickson, T. N., Hartley, J. W., and Hopkins, N. (1989). Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63, 328-337.
67. Goyns, M. H., Hann, I. M., Stewart, J., Gegonne, A., and Birnie, G. D. (1987). The c-ets-1 proto-oncogene is rearranged in some cases of acute lymphoblastic leukaemia. Br. J. Cancer 56, 611-613.
68. Graves, B. J., Eisenberg, S. P., Coen, D. M., and McKnight, S. L. (1985). Alternate utilization of two regulatory domains within the Moloney murine sarcoma virus long terminal repeat. Mol. Cell Biol. 5, 1959-1968.
69. Graves, B. J., Johnson, P. F., and McKnight, S. L. (1986). Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell 44, 565-576.
70. Gunther, C. V., and Graves, B. J. (1994). Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer. Mol. Cell Biol. 14, 7569-7580.
71. Habets, G. G., Scholtes, E. H., Zuydgeest, D., van der Kammen, R. A., Stam, J. C., Berns, A., and Collard, J. G. (1994). Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77, 537-549.
72. Hall, M., and Peters, G. (1996). Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68, 67-108.
73. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
74. Hanna, Z., Jankowski, M., Tremblay, P., Jiang, X., Milatovich, A., Francke, U., and Jolicoeur, P. (1993). The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2. Oncogene 8, 1661-1666.
75. Hansen, G. M., and Justice, M. J. (1999). Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia. Oncogene 18, 6531-6539.
76. Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P., and Adams, J. M. (1991). Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice [see comments]. Cell 65, 753-763.
77. Heidmann, O., and Heidmann, T. (1991). Retrotransposition of a mouse IAP sequence tagged with an indicator gene. Cell 64, 159-170.
78. Hengen, P. N. (1995). Vectorette, splinkerette and boomerang DNA amplification. Trends Biochem. Sci. 20, 372-373.
79. Hicks, G. G., and Mowat, M. (1988). Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J. Virol. 62, 4752-4755.
80. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., Muhammad Tunio, G., Matsuzawa, Y., Kanakura, Y., Shinomura, Y., and Kitamura, Y. (1998). Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580.
81. Hoglund, M., Johansson, B., Pedersen-Bjergaard, J., Marynen, P., and Mitelman, F. (1996). Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87, 324-330.
82. Hovanes, K., Li, T. W., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence Marsh, J., Holcombe, R. F., and Waterman, M. L. (2001). Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 28, 53-57.
83. Hwang, H. C., Martins, C. P., Bronkhorst, Y., Randel, E., Berns, A., Fero, M., and Clurman, B. E. (2002). Identification of p27 complementing oncogenes by insertional mutagenesis and high-throughput insertion site analysis. Proc. Natl. Acad. Sci. USA 99, 11293-11298.
84. Ihle, J. N., Smith-White, B., Sisson, B., Parker, D., Blair, D. G., Schultz, A., Kozak, C., Lunsford, R. D., Askew, D., Weinstein, Y. et al. (1989). Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia. J. Virol. 63, 2959-2966.
85. Ishibashi, Y., Maita, H., Yano, M., Koike, N., Tamai, K., Ariga, H., and Iguchi-Ariga, S. M. (2001). Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus. FEBS Lett. 506, 33-38.
86. Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., and Tuveson, D. A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248.
87. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A., and van Lohuizen, M. (1999). The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168.
88. Janssen, J. W., Steenvoorden, A. C., Lyons, J., Anger, B., Bohlke, J. U., Bos, J. L., Seliger, H., and Bartram, C. R. (1987). RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc. Natl. Acad. Sci. USA 84, 9228-9232.
89. Johnson, P., and Benchimol, S. (1992). Friend virus induced murine erythroleukaemia: the p53 locus. Cancer Surv. 12, 137-151.
90. Jonkers, J., and Berns, A. (2002). Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2, 251-265.
91. Jonkers, J., Korswagen, H. C., Acton, D., Breuer, M., and Berns, A. (1997). Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. EMBO J. 16, 441-450.
92. Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., and Berns, A. (2001). Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418-425.
93. Kacinski, B. M. (1995). CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann. Med. 27, 79-85.
94. Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., and Verma, I. M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
95. Kafri, T., van Praag, H., Ouyang, L., Gage, F. H., and Verma, I. M. (1999). A packaging cell line for lentivirus vectors. J. Virol. 73, 576-584.
96. Kamps, M. P., Murre, C., Sun, X. H., and Baltimore, D. (1990). A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60, 547-555.
97. Kohl, N. E., Kanda, N., Schreck, R. R., Bruns, G., Latt, S. A., Gilbert, F., and Alt, F. W. (1983). Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35, 359-367.
98. Koike, N., Maita, H., Taira, T., Ariga, H., and Iguchi-Ariga, S. M. (2000). Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1(1). FEBS Lett. 467, 17-21.
99. Kono, T., Doi, T., Yamada, G., Hatakeyama, M., Minamoto, S., Tsudo, M., Miyasaka, M., Miyata, T., and Taniguchi, T. (1990). Murine interleukin 2 receptor beta chain: dysregulated gene expression in lymphoma line EL-4 caused by a promoter insertion. Proc. Natl. Acad. Sci. USA 87, 1806-1810.
100. Kristensen, V. N., Andersen, T. I., Lindblom, A., Erikstein, B., Magnus, P., and Borresen-Dale, A. L. (1998). A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics 8, 43-48.
101. Kristensen, V. N., Harada, N., Yoshimura, N., Haraldsen, E., Lonning, P. E., Erikstein, B., Karesen, R., Kristensen, T., and Borresen-Dale, A. L. (2000). Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 19, 1329-1333.
102. Kuff, E. L., and Lueders, K. K. (1988). The intracisternal A-particle gene family: structure and functional aspects. Adv. Cancer Res. 51, 183-276.
103. Lacombe, C., Chretien, S., Lemarchandel, V., Mayeux, P., Romeo, P. H., Gisselbrecht, S., and Cartron, J. P. (1991). Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3Cl-2 friend leukemia cell line. J. Biol. Chem. 266, 6952-6956.
104. Laimins, L. A., Gruss, P., Pozzatti, R., and Khoury, G. (1984). Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus. J. Virol. 49, 183-189.
105. Lammie, G. A., Smith, R., Silver, J., Brookes, S., Dickson, C., and Peters, G. (1992). Proviral insertions near cyclin D1 in mouse lymphomas: A parallel for BCL1 translocations in human B-cell neoplasms. Oncogene 7, 2381-2387.
106. Langdon, W. Y., Harris, A. W., Cory, S., and Adams, J. M. (1986). The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47, 11-18.
107. Largaespada, D. A., Shaughnessy, J. D., Jr., Jenkins, N. A., and Copeland, N. G. (1995). Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J. Virol. 69, 5095-5102.
108. Lavu, S., and Reddy, E. P. (1986). Structural organization and nucleotide sequence of mouse c-myb oncogene: activation in ABPL tumors is due to viral integration in an intron which results in the deletion of the 5′ coding sequences. Nucleic Acids Res. 14, 5309-5320.
109. Le Couedic, J. P., Mitjavila, M. T., Villeval, J. L., Feger, F., Gobert, S., Mayeux, P., Casadevall, N., and Vainchenker, W. (1996). Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood 87, 1502-1511.
110. Lee, F. S., Lane, T. F., Kuo, A., Shackleford, G. M., and Leder, P. (1995). Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc. Natl. Acad. Sci. USA 92, 2268-2272.
111. Lee, W. H., Murphree, A. L., and Benedict, W. F. (1984). Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309, 458-460.
112. Lemay, G., and Jolicoeur, P. (1984). Rearrangement of a DNA sequence homologous to a cell-virus junction fragment in several Moloney murine leukemia virus-induced rat thymomas. Proc. Natl. Acad. Sci. USA 81, 38-42.
113. Leung, H. Y., Dickson, C., Robson, C. N., and Neal, D. E. (1996). Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene 12, 1833-1835.
114. Leverson, J. D., Koskinen, P. J., Orrico, F. C., Rainio, E. M., Jalkanen, K. J., Dash, A. B., Eisenman, R. N., and Ness, S. A. (1998). Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell 2, 417-425.
115. Li, J., Shen, H., Himmel, K. L., Dupuy, A. J., Largaespada, D. A., Nakamura, T., Shaughnessy, J. D., Jr., Jenkins, N. A., and Copeland, N. G. (1999). Leukaemia disease genes: large-scale cloning and pathway predictions. Nat. Genet. 23, 348-353.
116. Li, J. P., and Baltimore, D. (1991). Mechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J. Virol. 65, 2408-2414.
117. Li, M., Huang, X., Zhu, Z., and Gorelik, E. (1999). Sequence and insertion sites of murine melanoma-associated retrovirus. J. Virol. 73, 9178-9186.
118. Li, M., Xu, F., Muller, J., Hearing, V. J., and Gorelik, E. (1998). Ecotropic C-type retrovirus of B16 melanoma and malignant transformation of normal melanocytes. Int. J. Cancer 76, 430-436.
119. Li, Q. L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K., Chi, X. Z., Lee, K. Y., Nomura, S., Lee, C. W., Han, S. B., Kim, H. M., Kim, W. J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, A., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S. C., and Ito, Y. (2002). Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113-124.
120. Li, Z., Dullmann, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O., Ostertag, W., Kuhlcke, K., Eckert, H. G., Fehse, B., and Baum, C. (2002). Murine leukemia induced by retroviral gene marking. Science 296, 497.
121. Liao, X., Du, Y., Morse, H. C., 3rd, Jenkins, N. A., and Copeland, N. G. (1997). Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins. Oncogene 14, 1023-1029.
122. Lois, C., Hong, E. J., Pease, S., Brown, E. J., and Baltimore, D. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872.
123. Lu, S. J., Rowan, S., Bani, M. R., and Ben-David, Y. (1994). Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: Evidence that NF-E2 is essential for globin expression. Proc. Natl. Acad. Sci. USA 91, 8398-8402.
124. Lund, A., Turner, G., Trubetskoy, A., Verhoeven, E., Wientjens, E., Hulsman, D., Russell, R., DePinho, R. A., Lenz, J., and van Lohuizen, M. (2002). Genome-wide retroviral insertional tagging of cancer genes in Cdkn2a-deficient mice. Nat. Genet. 32, 160-165.
125. MacArthur, C. A., Shankar, D. B., and Shackleford, G. M. (1995). Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J. Virol. 69, 2501-2507.
126. Maita, H., Harada, Y., Nagakubo, D., Kitaura, H., Ikeda, M., Tamai, K., Takahashi, K., Ariga, H., and Iguchi-Ariga, S. M. (2000). PAP-1, a novel target protein of phosphorylation by pim-1 kinase. Eur. J. Biochem. 267, 5168-5178.
127. Makris, A., Patriotis, C., Bear, S. E., and Tsichlis, P. N. (1993). Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: Activation by provirus insertion. J. Virol. 67, 4283-4289.
128. Malik, H. S., and Eickbush, T. H. (1999). Retrotransposable elements R1 and R2 in the rDNA units of Drosophila mercatorum: Abnormal abdomen revisited. Genetics 151, 653-665.
129. Marchetti, A., Buttitta, F., Miyazaki, S., Gallahan, D., Smith, G. H., and Callahan, R. (1995). Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J. Virol. 69, 1932-1938.
130. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J., and Berns, A. (2000). Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994-1004.
131. Marth, J. D., Disteche, C., Pravtcheva, D., Ruddle, F., Krebs, E. G., and Perlmutter, R. M. (1986). Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas. Proc. Natl. Acad. Sci. USA 83, 7400-7404.
132. Martin-Hernandez, J., Sorensen, A. B., and Pedersen, F. S. (2001). Murine leukemia virus proviral insertions between the N-ras and unr genes in B-cell lymphoma DNA affect the expression of N-ras only. J. Virol. 75, 11907-11912.
133. Masuda, H., Battifora, H., Yokota, J., Meltzer, S., and Cline, M. J. (1987). Specificity of protooncogene amplification in human malignant diseases. Mol. Biol. Med. 4, 213-227.
134. Metzstein, M. M., Stanfield, G. M., and Horvitz, H. R. (1998). Genetics of programmed cell death in C. elegans: Past, present and future. Trends Genet. 14, 410-416.
135. Meuwissen, R., Linn, S. C., van der Valk, M., Mooi, W. J., and Berns, A. (2001). Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 20, 6551-6558.
136. Mikkers, H., and Berns, A. (2002). Proviral tagging of the tumor suppressor E2a contributes to T cell lymphomagenesis in EμMyc transgenic mice. Oncogene 21, 6559-6566.
137. Mikkers, H., Knipscheer, P., Romeyn, L., Hart, A., Vink, E., and Berns, A. (2002). High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat. Genet. 32, 153-159.
138. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. (1991). t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431-10434.
139. Mochizuki, T., Kitanaka, C., Noguchi, K., Muramatsu, T., Asai, A., and Kuchino, Y. (1999). Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J. Biol. Chem. 274, 18659-18666.
140. Moloney, J. B. (1960). Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J. Natl. Cancer Inst. 24, 933-951.
141. Mooslehner, K., Karls, U., and Harbers, K. (1990). Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions. J. Virol. 64, 3056-3058.
142. Moran, J. V., Holmes, S. E., Naas, T. P., DeBerardinis, R. J., Boeke, J. D., and Kazazian, H. H., Jr. (1996). High frequency retrotransposition in cultured mammalian cells. Cell 87, 917-927.
143. Moreau-Gachelin, F., Ray, D., Mattei, M. G., Tambourin, P., and Tavitian, A. (1989). The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene 4, 1449-1456.
144. Morishita, K., Parganas, E., William, C. L., Whittaker, M. H., Drabkin, H., Oval, J., Taetle, R., Valentine, M. B., and Ihle, J. N. (1992). Activation of EVII gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. USA 89, 3937-3941.
145. Morishita, K., Parker, D. S., Mucenski, M. L., Jenkins, N. A., Copeland, N. G., and Ihle, J. N. (1988). Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54, 831-840.
146. Morris, D. W. (1991). MolecularMolecular biology & pathogenesis of MMTV. Rev. Med. Virol. 1,223-233.
147. Morris, V. L., Rao, T. R., Kozak, C. A., Gray, D. A., Lee Chan, E. C., Cornell, T. J., Taylor, C. B., Jones, R. F., and McGrath, C. M. (1991). Characterization of Int-5, a locus associated with early events in mammary carcinogenesis. Oncogene Res. 6, 53-63.
148. Mucenski, M. L., Taylor, B. A., Jenkins, N. A., and Copeland,N. G. (1986). AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas. Mol. Cell Biol. 6, 4236-4243.
149. Mueller, R. E., Baggio, L., Kozak, C. A., and Ball, J. K. (1992). A common integration locus in type B retrovirus-induced thymic lymphomas. Virology 191, 628-637.
150. Mukhopadhyaya, R., and Wolff, L. (1992). New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J. Virol. 66, 6035-6044.
151. Muller, H. P., and Varmus, H. E. (1994). DNA bending creates favored sites for retroviral integration: An explanation for preferred insertion sites in nucleosomes. EMBO J. 13, 4704-4714.
152. Nakamura, T., Largaespada, D. A., Lee, M. P., Johnson, L. A., Ohyashiki, K., Toyama, K., Chen, S. J., Willman, C. L., Chen, I. M., Feinberg, A. P., Jenkins, N. A., Copeland, N. G., and Shaughnessy, J. D., Jr. (1996). Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7; 11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12, 154-158.
153. Nakamura, T., Largaespada, D. A., Shaughnessy, J. D., Jr., Jenkins, N. A., and Copeland, N. G. (1996). Cooperative activation of Hoxa and Pbxl-related genes in murine myeloid leukaemias. Nat. Genet. 12, 149-153.
154. Nakamura, T., Yamazaki, Y., Saiki, Y., Moriyama, M., Largaespada, D. A., Jenkins, N. A., and Copeland, N. G. (2000). Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product. Mol. Cell Biol. 20, 3178-3186.
155. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
156. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
157. Naldini, L., and Verma, I. M. (2000). Lentiviral vectors. Adv. Virus Res. 55, 599-609.
158. Nasmyth, K. (1996). At the heart of the budding yeast cell cycle. Trends Genet. 12, 405-412.
159. Neil, J. C., Hughes, D., McFarlane, R., Wilkie, N. M., Onions, D. E., Lees, G., and Jarrett, O. (1984). Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature 308, 814-820.
160. Nielsen, A. L., Pallisgaard, N., Pedersen, F. S., and Jorgensen, P. (1992). Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol. Cell Biol. 12, 3449-3459.
161. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P. et al. (1989). Mutations in the p53 gene occur in diverse human turnout types. Nature 342, 705-708.
162. Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., and Cleary, M. L. (1990). Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60, 535-545.
163. Nusse, R., and Varmus, H. E. (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31, 99-109.
164. O'Connell, P., Leach, R., Cawthon, R. M., Culver, M., Stevens, J., Viskochil, D., Fournier, R. E., Rich, D. C., Ledbetter, D. H., and White, R. (1989). Two NF1 translocations map within a 600-kilobase segment of 17q11.2. Science 244, 1087-1088.
165. O'Donnell, P. V., Fleissner, E., Lonial, H., Koehne, C. F., and Reicin, A. (1985). Early clonality and high-frequency proviral integration into the c-myc locus in AKR leukemias. J. Virol. 55, 500-503.
166. Oda, Y., Nagasu, T., and Chair, B. T. (2001). Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19, 379-382.
167. Ostertag, E. M., and Kazazian, H. H., Jr. (2001). Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 35, 501-538.
168. Ostertag, E. M., Prak, E. T., DeBerardinis, R. J., Moran, J. V., and Kazazian, H. H., Jr. (2000). Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res. 28, 1418-1423.
169. Patriotis, C., Makris, A., Bear, S. E., and Tsichlis, P. N. (1993). Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc. Natl. Acad. Sci. USA 90, 2251-2255.
170. Pelicci, P. G., Lanfrancone, L., Brathwaite, M. D., Wolman, S. R., and Dalla-Favera, R. (1984). Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 224, 1117-1121.
171. Peters, G., Brookes, S., Smith, R., and Dickson, C. (1983). Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Cell 33, 369-377.
172. Peters, G., Brookes, S., Smith, R., Placzek, M., and Dickson, C. (1989). The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc. Natl. Acad. Sci. USA 86, 5678-5682.
173. Pryciak, P. M., Sil, A., and Varmus, H. E. (1992). Retroviral integration into minichromosomes in vitro. EMBO J. 11, 291-303.
174. Pryciak, P. M., and Varmus, H. E. (1992). Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69, 769-780.
175. Rainio, E. M., Sandholm, J., and Koskinen, P. J. (2002). Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase. J. Immunol. 168, 1524-1527.
176. Reynolds, T. C., Smith, S. D., and Sklar, J. (1987). Analysis of DNA surrounding the break-points of chromosomal translocations involving the beta T cell receptor gene in human lymphoblastic neoplasms. Cell 50, 107-117.
177. Roberts, T., Chernova, O., and Cowell, J. K. (1998). NB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastoma. Hum. Mol. Genet. 7, 1169-1178.
178. Roelink, H., Wagenaar, E., Lopes da Silva, S., and Nusse, R. (1990). Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Proc. Natl. Acad. Sci. USA 87, 4519-4523.
179. Rohdewohld, H., Weiher, H., Reik, W., Jaenisch, R., and Breindl, M. (1987). Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J. Virol. 61, 336-343.
180. Rosenberg, C. L., Wong, E., Petty, E. M., Bale, A. E., Tsujimoto, Y., Harris, N. L., and Arnold, A. (1991). PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 88, 9638-9642.
181. Rosson, D., Dugan, D., and Reddy, E. P. (1987). Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation. Proc. Natl. Acad. Sci. USA 84, 3171-3175.
182. Rovigatti, U., Watson, D. K., and Yunis, J. J. (1986). Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of 11q23. Science 232, 398-400.
183. Rozovskaia, T., Feinstein, E., Mor, O., Foa, R., Blechman, J., Nakamura, T., Croce, C. M., Cimino, G., and Canaani, E. (2001). Upregulation of Meis 1 and HoxA9 in acute lymphocytic leukemias with the t(4: 11) abnormality. Oncogene 20, 874-878.
184. Sacchi, N., Watson, D. K., Guerts van Kessel, A. H., Hagemeijer, A., Kersey, J., Drabkin, H. D., Patterson, D., and Papas, T. S. (1986). Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and (8;21) translocations. Science 231, 379-382.
185. Saitoh, T., and Katoh, M. (2001). FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer. Int. J. Oncol. 19, 311-315.
186. Salmons, B., and Gunzburg, W. H. (1987). Current perspectives in the biology of mouse mammary tumour virus. Virus Res. 8, 81-102.
187. Santos, E., Martin-Zanca, D., Reddy, E. P., Pierotti, M. A., Della Porta, G., and Barbacid, M. (1984). Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 223, 661-664.
188. Satterwhite, E., Sonoki, T., Willis, T. G., Harder, L., Nowak, R., Arriola, E. L., Liu, H., Price, H. P., Gesk, S., Steinemann, D., Schlegelberger, B., Oscier, D. G., Siebert, R., Tucker, P. W., and Dyer, M. J. (2001). The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98, 3413-3420.
189. Scheijen, B., Jonkers, J., Acton, D., and Berns, A. (1997). Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J. Virol. 71, 9-16.
190. Scherdin, U., Rhodes, K., and Breindl, M. (1990). Transcriptionally active genome regions are preferred targets for retrovirus integration. J. Virol. 64, 907-912.
191. Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V., and Levinson, A. D. (1984). Biological properties of human c-Ha-rasl genes mutated at codon 12. Nature 312, 71-75.
192. Selten, G., Cuypers, H. T., and Berns, A. (1985). Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J. 4, 1793-1798.
193. Selten, G., Cuypers, H. T., Zijlstra, M., Melief, C., and Berns, A. (1984). Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J. 3, 3215-3222.
194. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
195. Setoguchi, M., Higuchi, Y., Yoshida, S., Nasu, N., Miyazaki, Y.,Akizuki, S., and Yamamoto, S. (1989). Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids. Mol. Cell Biol. 9, 4515-4522.
196. Shaughnessy, J. D., Jr., Largaespada, D. A., Tian, E., Fletcher, C. F., Cho, B. C., Vyas, P., Jenkins, N. A., and Copeland, N. G. (1999). Mrvil, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jawl. Oncogene 18, 2069-2084.
197. Shen-Ong, G. L., Potter, M., Mushinski, J. F., Lavu, S., and Reddy, E. P. (1984). Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science 226, 1077-1080.
198. Sheppard, R. D., Samant, S. A., Rosenberg, M., Silver, L. M., and Cole, M. D. (1998). Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors. Oncogene 17, 2073-2085.
199. Sherr, C. J. (2001). The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2, 731-737.
200. Simpson, R. J., and Dorow, D. S. (2001). Cancer proteomics: From signaling networks to tumor markers. Trends Biotechnol. 19, S40-48.
201. Skuse, G. R., Kosciolek, B. A., and Rowley, P. T. (1989). Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer 1, 36-41.
202. Smit, A. F. (1999). Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 9, 657-663.
203. Smith, H. O., Anderson, P. S., Kuo, D. Y., Goldberg, G. L., DeVictoria, C. L., Boocock, C. A., Jones, J. G., Runowicz, C. D., Stanley, E. R., and Pollard, J. W. (1995). The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin. Cancer Res. 1, 313-325.
204. Sorensen, A. B., Duch, M., Amtoft, H. W., Jorgensen, P., and Pedersen, F. S. (1996). Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3. J. Virol. 70, 4063-4070.
205. Sorensen, A. B., Lund, A. H., Ethelberg, S., Copeland, N. G., Jenkins, N. A., and Pedersen, F. S. (2000). Sintl, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. J. Virol. 74, 2161-2168.
206. Sourvinos, G., Tsatsanis, C., and Spandidos, D. A. (1999). Overexpression of the Tpl-2/Cot oncogene in human breast cancer. Oncogene 18, 4968-4973.
207. Steffen, D. (1984). Proviruses are adjacent to c-myc in some murine leukemia virus-induced lymphomas. Proc. Natl. Acad. Sci. USA 81, 2097-2101.
208. Sternberg, P. W., and Han, M. (1998). Genetics of RAS signaling in C. elegans. Trends Genet. 14, 466-472.
209. Stewart, M., MacKay, N., Cameron, E. R., and Neil, J. C. (2002). The common retroviral insertion locus Dsil maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene. J. Virol. 76, 4364-4369.
210. Stewart, M., Terry, A., Hu, M., O'Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D. E., and Neil, J. C. (1997). Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): Evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA 94, 8646-8651.
211. Stewart, M., Terry, A., O'Hara, M., Cameron, E., Onions, D., and Neil, J. C. (1996). til-1: A novel proviral insertion locus for Moloney murine leukaemia virus in lymphomas of CD2-myc transgenic mice. J. Gen. Virol. 77, 443-446.
212. Stulik, J., Koupilova, K., Osterreicher, J., Knizek, J., Macela, A., Bures, J., Jandik, P., Langr, E, Dedic, K., and Jungblut, P. R. (1999). Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20, 3638-3646. [pii].
213. Sugita, T., Totsuka, T., Saito, M., Yamasaki, K., Taga, T., Hirano, T., and Kishimoto, T. (1990). Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis. J. Exp. Med. 171, 2001-2009.
214. Sun, W., Graves, B. J., and Speck, N. A. (1995). Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69, 4941-4949.
215. Suzuki, T., Shen, H., Akagi, K., Morse, H. C., Malley, J. D., Naiman, D. Q., Jenkins, N. A., and Copeland, N. G. (2002). Retroviral tagging provides a potent cancer gene discovery tool in the post-genome-sequence era. Nat. Genet. 32, 166-174.
216. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. (1989). p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491-494.
217. Takano, Y., Kato, Y., Masuda, M., Ohshima, Y., and Okayasu, I. (1999). Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J. Pathol. 189, 194-200.
218. Taparowsky, E., Suard, Y., Fasano, O., Shimizu, K., Goldfarb, M., and Wigler, M. (1982). Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300, 762-765.
219. Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., and Leder, P. (1982). Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 79, 7837-7841.
220. Tian, E., Sawyer, J. R., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., and Shaughnessy, J. D., Jr. (2000). Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 19, 2098-2109.
221. Tian, Q., Frierson, H. F., Jr., Krystal, G. W., and Moskaluk, C. A. (1999). Activating c-kit gene mutations in human germ cell tumors. Am. J. Pathol. 154, 1643-1647.
222. Tohyama, K., Lee, K. H., Tashiro, K., Kinashi, T., and Honjo, T. (1990). Establishment of an interleukin-5-dependent subclone from an interleukin-3-dependent murine hemopoietic progenitor cell line, LyD9, and its malignant transformation by autocrine secretion of interleukin-5. EMBO J. 9, 1823-1830.
223. Tremblay, P. J., Kozak, C. A., and Jolicoeur, P. (1992). Identification of a novel gene, Vin-1, in murine leukemia virus-induced T-cell leukemias by provirus insertional mutagenesis. J. Virol. 66, 1344-1353.
224. Trusko, S. P., Hoffman, E. K., and George, D. L. (1989). Transcriptional activation of cKi-ras proto-oncogene resulting from retroviral promoter insertion. Nucleic Acids Res. 17, 9259-9265.
225. Tsichlis, P. N., Strauss, P. G., and Hu, L. F. (1983). A common region for proviral DNA integration in MoMuLV-induced rat thymic lymphomas. Nature 302, 445-449.
226. Tsujimoto, Y., Yunis, J., Onorato-Showe, L., Erikson, J., Nowell, P. C., and Croce, C. M. (1984). Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224, 1403-1406.
227. Tycko, B., Smith, S. D., and Sklar, J. (1991). Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia. J. Exp. Med. 174, 867-873.
228. Upadhyaya, M., Shen, M., Cherryson, A., Farnham, J., Maynard, J., Huson, S. M., and Harper, P. S. (1992). Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum. Mol. Genet. 1,735-740.
229. van der Lugt, N. M., Domen, J., Verhoeven, E., Linders, K., van der Gulden, H., Allen, J., and Berns, A. (1995). Proviral tagging in Eμ-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 14, 2536-2544.
230. van Leeuwen, E, and Nusse, R. (1995). Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer. Semin. Cancer Biol. 6, 127-133.
231. van Lohuizen, M., Breuer, M., and Berns, A. (1989). N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO J. 8, 133-136.
232. van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., van der Gulden, H., and Berns, A. (1991). Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging [see comments]. Cell 65, 737-752.
233. Verbeek, S., van Lohuizen, M., van der Valk, M., Domen, J., Kraal, G., and Berns, A. (1991). Mice bearing the Eμ-myc and Eμ-pim-1 trans Genes Dev. elop pre-B-cell leukemia prenatally. Mol. Cell Biol. 11, 1176-1179.
234. Vigna, E., and Naldini, L. (2000). Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. 2, 308-316.
235. Vijaya, S., Steffen, D. L., and Robinson, H. L. (1986). Acceptor sites for retroviral integrations map near DNase I- hypersensitive sites in chromatin. J. Virol. 60, 683-692.
236. Vooijs, M., van der Valk, M., te Riele, H., and Berns, A. (1998). Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 17, 1-12.
237. Voronova, A. F., Adler, H. T., and Sefton, B. M. (1987). Two lck transcripts containing different 5′ untranslated regions are present in T cells. Mol. Cell Biol. 7, 4407-4413.
238. Wallrapp, C., Muller-Pillasch, E, Solinas-Toldo, S., Lichter, P., Friess, H., Buchler, M., Fink, T., Adler, G., and Gress, T. M. (1997). Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res. 57, 3135-3139.
239. Wassarman, D. A., Therrien, M., and Rubin, G. M. (1995). The Ras signaling pathway in Drosophila. Curr. Opin. Genet. Dev. 5, 44-50.
240. Westaway, D., Payne, G., and Varmus, H. E. (1984). Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors. Proc. Natl. Acad. Sci. USA 81, 843-847.
241. Withers-Ward, E. S., Kitamura, Y., Barnes, J. P., and Coffin, J. M. (1994). Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev. 8, 1473-1487.
242. Wotton, D., Ghysdael, J., Wang, S., Speck, N. A., and Owen, M. J. (1994). Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell Biol. 14, 840-850.
243. Ymer, S., Tucker, W. Q., Sanderson, C. J., Hapel, A. J., Campbell, H. D., and Young, I. G. (1985). Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature 317, 255-258.
244. Yuasa, Y., Srivastava, S. K., Dunn, C. Y., Rhim, J. S., Reddy, E. P., and Aaronson, S. A. (1983). Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature 303, 775-779.
245. Zhou, H., Watts, J. D., and Aebersold, R. (2001). A systematic approach to the analysis of protein phosphorylation. Nat. Biotechnol. 19, 375-378.